Sequence Similarity Clusters for the Entities in PDB 1NC4

Entity #1 | Chains: A,C
MONOCLONAL ANTIBODY 2D12.5, LAMBDA LIGHT CHAIN protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 8 7864
95 % 13 39 542 Flexibility: Low
Max RMSD: 8.9, Avg RMSD: 2.4
PDBFlex
90 % 15 45 493
70 % 1018 2670 1
50 % 2089 5421 1
40 % 2403 6121 1
30 % 2916 7588 1
Entity #2 | Chains: B
MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY CHAIN protein, length: 221 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 4 24936
95 % 3 4 22189 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 1.3
PDBFlex
90 % 7 11 5018
70 % 1009 2629 2
50 % 2090 5421 1
40 % 2404 6121 1
30 % 2917 7588 1
Entity #3 | Chains: D
MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY CHAIN protein, length: 221 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 4 4 24936
95 % 4 4 22189 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 1.3
PDBFlex
90 % 8 11 5018
70 % 1010 2629 2
50 % 2091 5421 1
40 % 2405 6121 1
30 % 2918 7588 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
3 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
4 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
5 5IVN 1 A BC2-nanobody 30538
6 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
7 5E7B 1 A nanobody nano-L06 9838
8 2P45 2 B ANTIBODY CAB-RN05 9838
9 2X1Q 1 A, B GELSOLIN NANOBODY 9844
10 5U64 1 B VHH-28 9838
11 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
12 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
13 4B41 1 A, B ANTIBODY G7 9844
14 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
15 4NZU 1 L 13PL heavy chain Fab 9606
16 4NZU 2 H 13PL light chain Fab 9606
17 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
18 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
19 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
20 5IMM 1 B Nanobody 9835
21 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
22 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
23 5NLU 1 A single domain llama antibody Nb36 9844
24 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
25 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
27 1MEX 1 L Fab 29G12 light chain 10090
28 1MEX 2 H Fab 29G12 heavy chain 10090
29 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
30 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
31 5IMK 1 B Nanobody 9835
32 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
33 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
34 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
35 6EH4 2 E Human T Cell Receptor Beta Chain 9606
36 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
37 4BUH 1 A, B CLONE M0418 SCFV 9606
38 4B50 1 A 2H10 LLAMA VHH 9844
39 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
40 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
41 6FR4 1 A TCR 003 alpha chain 9606
42 6FR4 2 B TCR 003 Beta Chain 9606
43 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
44 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
45 6DBA 1 A, B nanobody VHH R303 9838
46 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
47 6EH5 2 B Human T Cell Receptor Beta Chain 9606
48 5YD4 1 A, C, E, G scFv 4B08 10090
49 5YD3 1 A, C, E, G scFv 4B08 10090
50 2XT1 2 B CAMELID VHH 9 30538
51 5UD9 1 H Fab heavy chain 9606
52 5UD9 2 L Light chain 9606
53 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
54 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
55 4P48 1 A Antibody scFv 180 9031
56 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
57 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
58 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
59 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
60 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
61 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
62 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
63 6FR3 1 A 003 TCR Alpha Chain 9606
64 6FR3 2 B 003 TCR Beta Chain 9606
65 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
66 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
67 5J1S 3 C VHH domain BS-2 30538
68 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
69 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
70 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
71 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
72 6BJZ 1 H 5c8 Fab Heavy chain 9606
73 6BJZ 2 L 5c8 Fab Light chain 9606
74 5L6Q 1 A, B H5AL 9606
75 5J1T 3 C VHH domain BS-2 30538
76 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
77 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
78 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
79 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
80 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
81 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
82 4XCF 1 L 4E10 Fab light chain 9606
83 4XCF 2 H 4E10 Fab heavy chain 9606
84 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
85 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
86 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
87 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
88 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
89 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
90 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
91 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
92 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
93 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
94 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
95 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
96 5X08 1 H Fab 4E10 Heavy chain 9606
97 5X08 2 L Fab 4E10 Light chain 9606
98 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
99 2X1O 1 A, B GELSOLIN NANOBODY 9844
100 4QGY 1 A, B nanobody n25, VH domain 9844
101 5C2B 1 H scFv 3B4 heavy chain 9606
102 5C2B 2 L 3B4 light chain 9606
103 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
104 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
105 4XAW 1 L 4E10 Fab light chain 9606
106 4XAW 2 H 4E10 Fab heavy chain 9606
107 5VNV 1 A Nb.b201 32630
108 4P49 1 A Antibody scFv B8 9031
109 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
110 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
111 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
112 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
113 5DXW 1 A PD-L1 nanobody 10090
114 2NW2 1 A ELS4 TCR alpha chain 9606
115 2NW2 2 B ELS4 TCR beta chain 9606
116 5UCB 1 H Fab Heavy Chain 9606
117 5UCB 2 L Fab Light Chain 9606
118 3T0W 1 A, B immunoglobulin variable lambda domain 9606
119 2VXV 1 H HUMAN IGG ABT-325 9606
120 2VXV 2 L HUMAN IGG ABT-325 9606
121 4N9O 2 B Nanobody Nb484 Nb484 9844
122 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
123 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
124 3T0V 1 A immunoglobulin variable lambda domain 9606
125 4GXV 1 H, I Antibody 1F1, heavy chain 9606
126 4GXV 2 L, M Antibody 1F1, light chain 9606
127 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
128 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
129 2VXT 1 H MURINE IGG 125-2H 10090
130 2VXT 3 L MURINE IGG 125-2H 10090
131 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
132 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
133 1T2J 1 A M12-Variable Heavy domain 9606
134 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
135 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
136 6DBF 2 B InlB specific VHH R303 9838
137 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
138 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
139 6DBG 2 C, D VHH R303 9838
140 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
141 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
142 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
143 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
144 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
145 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
146 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
147 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
148 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
149 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
150 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
151 5W24 1 L 5C4 Fab Light Chain 10090
152 5W24 2 H 5C4 Fab Heavy Chain 10090
153 4HPY 1 H CH59 Fab heavy chain 9606
154 4HPY 2 L CH59 Fab light chain 9606
155 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
156 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
157 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
158 5VM6 1 A single domain camelid nanobody VHH T10 9844
159 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
160 4JG1 1 L Fab light chain 9606
161 4JG1 2 H Fab heavy chain 9606
162 1SQ2 2 N novel antigen receptor 7801
163 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
164 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
165 4KML 2 B Nanobody 9844
166 5VF2 1 A scFv 2D10 10090
167 5I8C 1 A VRC34.01 Fab heavy chain 9606
168 5I8C 2 B VRC34.01 Fab light chain 9606
169 4O5L 1 L Fab F045-092 light chain 9606
170 4O5L 2 H Fab F045-092 heavy chain 9606
171 5MYX 1 A, C Fab c#24 light chain 10090
172 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
173 4Z9K 2 B VHH2(F5) antibody 30538
174 3IFL 1 L 12A11 FAB antibody light chain 10090
175 3IFL 2 H 12A11 FAB antibody heavy chain 10090
176 5WK2 1 L M116 LIGHT CHAIN 9606
177 5WK2 2 H M116 HEAVY CHAIN FD 9606
178 3PP4 1 H GA101 Fab heavy chain 10090
179 3PP4 2 L GA101 Fab light chain 10090
180 3KDM 1 A, L Immunoglobulin light chain 9606
181 3KDM 2 B, H Immunoglobulin heavy chain 9606
182 5NIV 1 A Light chain of 5D3 Fab 10090
183 5NIV 2 B Heavy chain of 5D3 Fab 10090
184 5N4J 1 L LIGHT CHAIN 9606
185 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
186 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
187 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
188 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
189 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
190 5X4G 1 A 6H8 Fab heavy chain 10090
191 5X4G 2 B 6H8 Fab light chain 10090
192 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
193 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
194 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
195 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
196 4PTU 1 A Antibody pn132p2C05, light chain 9606
197 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
198 4TPR 1 L If kappa light chain 10090
199 4TPR 2 H Fab heavy chain 10090
200 5LMW 1 A Nanobody 9844
201 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
202 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
203 3IFN 1 H 12A11 FAB antibody heavy chain 10090
204 3IFN 2 L 12A11 FAB antibody light chain 10090
205 5U3P 1 H DH511.4 Fab Heavy Chain 9606
206 5U3P 2 L DH511.4 Fab Light Chain 9606
207 6BLA 1 H AMM01 Fab Heavy chain 9606
208 6BLA 2 L AMM01 Fab Light chain 9606
209 5NM0 1 A, B, C, D Nb36 9844
210 4TOY 1 H 35O22 Fab Heavy chain 9606
211 4TOY 2 L 35O22 Fab Light chain 9606
212 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
213 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
214 3NPS 2 B S4 FAB HEAVY CHAIN 9606
215 3NPS 3 C S4 FAB LIGHT CHAIN 9606
216 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
217 5I4F 1 A scFv 2D10 10090
218 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
219 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
220 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
221 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
222 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
223 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
224 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
225 5WN9 1 H scFv 2D10 9606
226 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
227 4XC3 1 L 4E10 Fab light chain 9606
228 4XC3 2 H 4E10 Fab heavy chain 9606
229 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
230 4PPT 1 A Engineered single domain VHH antibody 9844
231 3R0M 1 A, B Llama VHH A12 9844
232 4M5Y 1 H, I Fab 5J8 heavy chain 9606
233 4M5Y 2 L, M Fab 5J8 light chain 9606
234 4TQE 1 L If kappa light chain 10090
235 4TQE 2 H Fab heavy chain 10090
236 3ZKQ 2 D XA4813 9844
237 5YY4 1 A scFv 4B08 10090
238 4I13 2 B Protein ca1697 (nanobody) 9844
239 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
240 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
241 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
242 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
243 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
244 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
245 5C2U 1 B Nanobody Nanobody 9838
246 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
247 5VSI 2 L CH1/Ckappa Fab light chain 9606
248 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
249 1XFP 1 A heavy chain antibody VHH domain 9838
250 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
251 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
252 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
253 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
254 5JXA 1 H VRC03 Heavy chain 9606
255 5JXA 2 L VRC03 Light chain 9606
256 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
257 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
258 4POY 1 A VHH-metal 9844
259 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
260 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
261 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
262 5NLW 1 A nanobody Nb36 9844
263 3CDC 1 A, B Light Chain Amyloidogenic 9606
264 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
265 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
266 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
267 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
268 3NTC 1 L Fab light chain 10090
269 3NTC 2 H Fab heavy chain 10090
270 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
271 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
272 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
273 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
274 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
275 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
276 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
277 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
278 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
279 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
280 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
281 6BE3 1 H Fab (F598) Heavy Chain 9606
282 6BE3 2 L Fab (F598) Light Chain 9606
283 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
284 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
285 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
286 3G9A 2 B Minimizer 9838
287 4NWU 1 H APE1551 Ab Fab heavy chain 9606
288 4NWU 2 L APE1551 Ab Fab light chain 9606
289 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
290 1KGC 1 D T-cell receptor alpha chain 9606
291 1KGC 2 E T-cell receptor beta chain 9606
292 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
293 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
294 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
295 6FRC 2 B Human T-Cell Receptor beta Chain 9606
296 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
297 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
298 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
299 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
300 5EWI 1 H VRC38.01 Heavy Chain 9606
301 5EWI 2 L VRC38.01 Light Chain 9606
302 5E2W 1 L AT8 LIGHT CHAIN 10090
303 5E2W 2 H AT8 HEAVY CHAIN 10090
304 5MYK 1 A Fab c#17 light chain 10090
305 5MYK 2 B Fab c#17 heavy chain 10090
306 6FUQ 1 A Human F11 T-Cell Receptor 9606
307 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
308 4NZR 1 H PGT135 heavy chain Fab 9606
309 4NZR 2 L PGT135 light chain Fab 9606
310 5MYO 1 A, C Fab c#6 light chain 10090
311 5MYO 2 B, D Fab c#6 heavy chain 10090
312 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
313 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
314 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
315 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
316 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
317 5UEL 1 H 354NC102 Fab Heavy Chain 9606
318 5UEL 2 L 354NC102 Fab Light Chain 9606
319 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
320 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
321 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
322 2P43 2 B ANTIBODY CAB-RN05 9838
323 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
324 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
325 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
326 5E2V 1 L AT8 LIGHT CHAIN 10090
327 5E2V 2 H AT8 HEAVY CHAIN 10090
328 4KRN 1 A Nanobody/VHH domain EgA1 9844
329 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
330 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
331 4GFT 2 B Nanobody 9844
332 4TVS 2 a, b VHH Domain BS-1 30538
333 4W6Y 2 B Nanobody NbFedF9 9844
334 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
335 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
336 6EZW 1 B VHH antibody BCD090-M2 9844
337 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
338 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
339 5JUE 1 L light chain of UIC2 Fab 10090
340 5JUE 2 H heavy chain of UIC2 Fab 10090
341 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
342 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
343 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
344 1UAC 2 H Ig VH,anti-lysozyme 10090
345 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
346 5JR1 1 H 10E8 heavy chain 9606
347 5JR1 2 L 10E8 mature light chain 9606
348 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
349 6CA7 1 L PCT64_13C light chain 9606
350 6CA7 2 H PCT64_13C heavy chain 9606
351 5VF6 1 A single chain variable fragment 9031
352 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
353 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
354 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
355 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
356 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
357 6FR9 2 B T-Cell Receptor F11 beta chain 9606
358 5OB5 2 H fAb Heavy chain 9606
359 5OB5 3 L fAb Light chain 9606
360 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
361 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
362 5I66 1 A 8B6 antibody, heavy chain 10090
363 5I66 2 B 8B6 antibody, light chain 10090
364 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
365 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
366 6BZY 1 H 22D11 Heavy Chain 10090
367 6BZY 2 L 22D11 Light Chain 10090
368 3QQ9 1 C, L 101F LIGHT CHAIN 10090
369 3QQ9 2 D, H 101F HEAVY CHAIN 10090
370 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
371 5TKK 3 L mouse antibody vFP5.01 light chain 10090
372 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
373 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
374 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
375 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
376 5W6C 1 H UCA Fab heavy chain 9606
377 5W6C 2 L UCA Fab light chain 9606
378 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
379 5I1K 1 L FAB LIGHT CHAIN 9606
380 5I1K 2 H FAB HEAVY CHAIN 9606
381 3OZ9 1 L Fab NC-1 kappa light chain 10090
382 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
383 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
384 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
385 5V7U 1 L CBTAU-22.1 Fab light chain 9606
386 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
387 5UEA 1 A, H Fab Heavy Chain 9606
388 5UEA 3 B, L Fab Light Chain 9606
389 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
390 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
391 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
392 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
393 3G5Y 1 A 175 light chain 10090
394 3G5Y 2 B 175 heavy chain 10090
395 5O02 2 C Nanobody (VHH) Nano-4 30538
396 5NMV 1 L Fab light chain 10088
397 5NMV 2 H Fab heavy chain 10088
398 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
399 4N8C 2 L, M Light chain of monoclonal antibody 10090
400 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
401 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
402 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
403 4HGW 1 A Antibody Fab fragment, light chain 10090
404 4HGW 2 B Antibody Fab fragment, heavy chain 10090
405 1NLB 1 L antibody 19D9D6 light chain 10090
406 1NLB 2 H antibody 19D9D6 heavy chain 10090
407 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
408 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
409 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
410 3VFG 1 L 3F8 Light Chain 10090
411 3VFG 2 H 3F8 Heavy Chain 10090
412 4X7F 2 C, D Nano-25 Nanobody 30538
413 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
414 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
415 3QRG 1 L Fab light chain 9606
416 3QRG 2 H Fab heavy chain Fd fragment 9606
417 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
418 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
419 5M6A 1 A, B, C, D Bence-Jones light chain 9606
420 4LLY 2 B, D light chain Clambda 9606
421 4LGR 2 B Camelid nanobody (VHH3) 30538
422 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
423 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
424 5EZI 1 H Fab c12 heavy chain 9606
425 5EZI 2 L Fab c12 Light chain 9606
426 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
427 4K23 1 H anti-uPAR antibody, heavy chain 10090
428 4K23 2 L anti-uPAR antibody, light chain 10090
429 5J57 2 B VHH single chain antibody V5E1 30538
430 3NCJ 1 L Fab15 Mut8 light chain 9606
431 3NCJ 2 H Fab15 Mut8 heavy chain 9606
432 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
433 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
434 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
435 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
436 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
437 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
438 5W05 1 L M59 FAB LIGHT CHAIN 10090
439 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
440 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
441 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
442 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
443 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
444 5OMM 2 C Nanobody (VHH) Nano-14 30538
445 5E03 1 A mouse CTLA-4 nanobody 10090
446 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
447 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
448 4M61 1 A, C Fab A52 light chain 10090
449 4M61 2 B, D Fab A52 heavy chain 10090
450 5YE3 1 B 2A7D9 VH CH1 chain 10090
451 5YE3 2 A 2A7D9 L chain 10090
452 5LZ0 1 A, B PorM nanobody 9844
453 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
454 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
455 1UM5 1 L Antibody 21H3 L chain 10090
456 1UM5 2 H Antibody 21H3 H chain 10090
457 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
458 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
459 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
460 4NWT 1 L APE1531 Ab Fab light chain 9606
461 4NWT 2 H APE1531 Ab Fab heavy chain 9606
462 6DBE 1 A, B nanobody VHH R303 9844
463 3WHX 1 A mAb Fab H fragment 10090
464 3WHX 2 B mAb Fab L fragment 10090
465 3NA9 1 L Fab15 light chain 9606
466 3NA9 2 H Fab15 heavy chain 9606
467 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
468 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
469 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
470 6FUO 2 B Human F11 T-Cell Receptor 9606
471 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
472 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
473 4LRI 1 A, B MSL-109 Light Chain 9606
474 4LRI 2 C, P MSL-109 Heavy Chain 9606
475 2XXC 1 B CAMELID VHH 9 30538
476 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
477 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
478 4JN2 1 A, L anti dabigatran Fab 10090
479 4JN2 2 B, H anti dabigatran Fab 10090
480 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
481 4XBE 2 H 4E10 Fab heavy chain 9606
482 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
483 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
484 6BE2 1 H Fab (F598) Heavy Chain 9606
485 6BE2 2 L Fab (F598) Light Chain 9606
486 3QYC 1 A, B VH domain of IgG molecule 9606
487 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
488 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
489 4JFZ 1 L Fab light chain 9606
490 4JFZ 2 H Fab heavy chain 9606
491 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
492 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
493 5VAK 2 B Nb914 Nanobody 9844
494 3WIF 1 A mAb Fab H fragment 10090
495 3WIF 2 B mAb Fab L fragment 10090
496 5U6A 1 A Light Chain 9606
497 5U6A 2 B Heavy Chain 9606
498 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
499 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
500 3MBX 1 L X836 LIGHT CHAIN 10090
501 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
502 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
503 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
504 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
505 2XXM 2 B CAMELID VHH 9 30538
506 6APC 1 H Epididymis luminal protein 214 9606
507 6APC 2 L IGL@ protein 9606
508 6BJ8 3 D TCR 55 alpha chain 9606
509 6BJ8 4 H TCR 55 beta chain 9606
510 5IR3 1 A Ig lambda chain V-VI region AR 9606
511 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
512 4HHA 1 A Fab KE5 Fab fragment KE5 9606
513 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
514 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
515 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
516 4RGO 2 H 14G8 heavy chain Fab 10090
517 4RGO 3 L 14G8 light chain Fab 10090
518 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
519 5GRY 1 A, G diabody 9606
520 5UEK 2 H Fab 12E Heavy Chain 9606
521 5UEK 3 L Fab 12E Light Chain 9606
522 3NAA 1 L Fab15 Mut5 light chain 9606
523 3NAA 2 H Fab15 Mut5 heavy chain 9606
524 6DBD 1 A, B, C, D nanobody VHH R326 9844
525 1Q0X 1 L Fab 9B1, light chain 10090
526 1Q0X 2 H Fab 9B1, heavy chain 10090
527 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
528 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
529 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
530 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
531 5JDS 1 B Nanobody 9835
532 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
533 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
534 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
535 5IK3 2 B, D 1E03 Fab fragment light chain 9606
536 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
537 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
538 5XLI 1 a, b FabL 10090
539 5XLI 2 c, d FabH 10090
540 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
541 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
542 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
543 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
544 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
545 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
546 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
547 4WUK 1 H CH65 heavy chain 9606
548 4WUK 2 L CH65 light chain 9606
549 5L8L 2 B New antigen receptor variable domain 168098
550 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
551 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
552 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
553 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
554 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
555 5JOP 1 D, L Fab 14.22 light chain 10090
556 5JOP 2 E, H Fab14.22 heavy chain 10090
557 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
558 4HPO 1 H CH58 Fab heavy chain 9606
559 4HPO 2 L CH58 Fab light chain 9606
560 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
561 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
562 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
563 5UKN 2 L DH522UCA Fab fragment light chain 9544
564 4AIZ 1 A, C, D V2-17 PROTEIN 9606
565 4AIZ 2 B V2-17 PROTEIN 9606
566 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
567 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
568 5L21 2 B VHH-C2 30538
569 5IT2 1 H heavy chain 9606
570 5IT2 2 L light chain 9606
571 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
572 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
573 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
574 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
575 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
576 2W59 1 A, B IGY FCU3-4 9031
577 5FWO 1 A NANOBODY 9844
578 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
579 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
580 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
581 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
582 4L1H 1 A Ig kappa chain V-I region Rei 9606
583 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
584 5MO3 3 L Fab of monoclonal antibody, light chain 10090
585 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
586 5GZ0 1 A, C FM329 light chain 1383439
587 5GZ0 2 B, D FM329 heavy chain 1383439
588 6DW2 1 A 6078 Fab light chain 9606
589 6DW2 2 B 6078 Fab heavy chain 9606
590 3B9V 1 A, B, C, D heavy chain variable domain 9606
591 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
592 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
593 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
594 6BQB 1 L MGG4 Fab light chain 9606
595 6BQB 2 H MGG4 Fab heavy chain 9606
596 4PUB 1 H DX-2930 HEAVY CHAIN 9606
597 4PUB 2 L DX-2930 LIGHT CHAIN 9606
598 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
599 6B14 2 L Light chain of Fab BL3-6S97N 10090
600 5N88 1 A, H VH59 antibody 9606
601 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
602 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
603 5TEZ 4 I TCR F50 alpha chain 9606
604 5TEZ 5 J TCR F50 beta chain 9606
605 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
606 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
607 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
608 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
609 5GS3 1 A, H diabody protein 9606
610 3BD3 1 A, B catalytic antibody 10090
611 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
612 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
613 2OTU 1 A, C, E, G Fv light chain variable domain 10090
614 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
615 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
616 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
617 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
618 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
619 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
620 5VKD 2 H Fab Heavy Chain 9606
621 5VKD 3 L Fab light chain 9606
622 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
623 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
624 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
625 5XHG 1 A, C polypeptide(L) 10090
626 5XHG 2 B, D polypeptide(H) 10090
627 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
628 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
629 5L8J 2 B New antigen receptor variable domain 168098
630 3UYR 1 H antibody Fab heavy chain 10090
631 3UYR 2 L antibody Fab light chain 10090
632 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
633 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
634 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
635 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
636 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
637 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
638 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
639 3OAZ 2 K, L Fab 2G12, light chain 9606
640 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
641 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
642 1T6V 2 N, O novel antigen receptor 7801
643 1ZAN 1 L Fab AD11 Light Chain 10116
644 1ZAN 2 H Fab AD11 Heavy Chain 10116
645 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
646 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
647 6CJK 1 A, C Immunoglobulin Fab light chain 9986
648 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
649 4N0Y 1 H IGH526 Heavy Chain 9606
650 4N0Y 2 L IGH526 Light Chain 9606
651 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
652 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
653 5MTH 1 A, H antibody Fab heavy chain 10090
654 5MTH 2 B, L antibody Fab light chain 10090
655 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
656 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
657 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
658 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
659 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
660 1RZF 1 L Fab E51 light chain 9606
661 1RZF 2 H Fab E51 heavy chain 9606
662 4N1C 1 A, B immunoglobulin variable light chain domain 9606
663 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
664 4KTE 2 L GE148 Light Chain Fab 9544
665 5I8O 1 H HMM5 antibody heavy chain 9606
666 5I8O 2 L HMM5 antibody light chain 9606
667 4OUO 1 A anti Bla g 1 scFv 9031
668 4JG0 1 L Fab light chain 9606
669 4JG0 2 H Fab heavy chain 9606
670 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
671 4YGV 2 B, L aDabi-Fab2a light chain 9606
672 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
673 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
674 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
675 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
676 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
677 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
678 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
679 3EO0 1 A, C GC-1008 Fab Light Chain 10090
680 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
681 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
682 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
683 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
684 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
685 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
686 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
687 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
688 6FUR 2 B, D Human F11 T-Cell Receptor 9606
689 4POU 2 B VHH Antibody 9844
690 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
691 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
692 4FQI 3 H antibody CR9114 heavy chain Fab 9606
693 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
694 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
695 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
696 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
697 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
698 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
699 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
700 4JHA 2 L D25 light chain 9606
701 6B9Z 1 A Trastuzumab Fab light chain 10090
702 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
703 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
704 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
705 4PTT 1 A Antibody pn132p2C05, light chain 9606
706 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
707 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
708 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
709 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
710 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
711 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
712 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
713 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
714 2P42 2 B, D ANTIBODY CAB-RN05 9838
715 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
716 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
717 6CPH 1 D TCR alpha chain 9606
718 6CPH 2 E TCR beta chain 9606
719 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
720 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
721 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
722 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
723 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
724 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
725 4DGV 1 H HCV1 Heavy Chain Fab 9606
726 4DGV 2 L HCV1 Light Chain 9606
727 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
728 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
729 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
730 5TH2 1 A, C cetuximab Fab, light chain 10090
731 5TH2 2 B, D cetuximab Fab, heavy chain 10090
732 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
733 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
734 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
735 5I8K 1 L HHH1 Fab Light chain 9606
736 5I8K 2 H HHH1 Fab Heavy chain 9606
737 4QLR 1 A, B Llama nanobody n02 VH domain 9844
738 5J56 2 B VHH single chain antibody V1C7 30538
739 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
740 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
741 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
742 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
743 1YNL 1 L Ig gamma light chain 10090
744 1YNL 2 H Ig gamma heavy chain 10090
745 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
746 5EPM 2 B, F Antibody Fab fragment light chain 10090
747 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
748 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
749 5VH5 1 A Infliximab Fc 10090
750 3UMT 1 A scFv heavy chain and light chain 10090
751 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
752 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
753 4NUJ 1 A PGT152 light chain 9606
754 4NUJ 2 B PGT152 heavy chain 9606
755 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
756 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
757 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
758 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
759 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
760 3U2S 2 B, L PG9 light chain 9606
761 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
762 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
763 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
764 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
765 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
766 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
767 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
768 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
769 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
770 4NUG 1 L PGT151 light chain 9606
771 4NUG 2 H PGT151 heavy chain 9606
772 3IU4 1 H chP3 Fab heavy chain 10090
773 3IU4 2 L chP3 Fab light chain 10090
774 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
775 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
776 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
777 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
778 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
779 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
780 1P7K 1 A, L antibody light chain FAB 10090
781 1P7K 2 B, H antibody heavy chain FAB 10090
782 4NBX 2 B A20.1 VHH 9844
783 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
784 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
785 3RVV 2 C 4C1 - light chain 10090
786 3RVV 3 D 4C1 - heavy chain 10090
787 4HEP 2 G vHH17 domain 9844
788 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
789 3P0Y 2 H Fab DL11 heavy chain 9606
790 3P0Y 3 L Fab DL11 light chain 9606
791 4NPY 1 A, L germline PGT121 light chain Fab 9606
792 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
793 6ANA 2 H LL2 Fab Heavy Chain 10090
794 6ANA 3 L LL2 Fab Light Chain 10090
795 5IBU 1 B, L 6652 Light Chain 9606
796 5IBU 2 G, H 6652 Heavy Chain 9606
797 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
798 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
799 5VPL 2 C 4C1 - LIGHT CHAIN 10090
800 5VPL 3 D 4C1 - HEAVY CHAIN 10090
801 6AOD 1 A FXIa Antibody FAB Light Chain 9606
802 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
803 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
804 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
805 2YPV 2 H FAB 12C1 10090
806 2YPV 3 L FAB 12C1 10090
807 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
808 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
809 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
810 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
811 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
812 4JY5 1 L PGT122 light chain Fab 9606
813 4JY5 2 H PGT122 heavy chain Fab 9606
814 6ELE 1 A, H fAB heavy chain 9606
815 6ELE 2 B, L fAB light chain 9606
816 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
817 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
818 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
819 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
820 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
821 6B5R 1 H CIS42 Fab Heavy chain 9606
822 6B5R 2 L CIS42 Fab Light chain 9606
823 5IML 2 B Nanobody 9835
824 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
825 3NAC 1 L Fab15 Mut7 light chain 9606
826 3NAC 2 H Fab15 Mut7 heavy chain 9606
827 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
828 3A6C 2 H IG VH, anti-lysozyme 10090
829 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
830 2DQD 2 H Ig VH,anti-lysozyme 10090
831 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
832 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
833 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
834 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
835 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
836 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
837 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
838 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
839 1Q72 1 L Fab M82G2, Light chain 10090
840 1Q72 2 H Fab M82G2, Heavy chain 10090
841 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
842 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
843 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
844 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
845 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
846 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
847 4YHO 1 H aDabi-Fab3 heavy chain 9606
848 4YHO 2 L aDabi-Fab3 light chain 9606
849 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
850 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
851 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
852 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
853 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
854 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
855 4DGY 1 H HCV1 Heavy Chain Fab 9606
856 4DGY 2 L HCV1 Light Chain 9606
857 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
858 3A67 2 H IG VH, anti-lysozyme 10090
859 2APB 1 A T-cell receptor beta chain V 10116
860 2APX 1 A T cell receptor beta chain V 10116
861 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
862 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
863 6EH6 2 B Human T Cell Receptor BetaChain 9606
864 5EN2 1 A GD01 heavy chain 10090
865 5EN2 2 B GD01 light chain 10090
866 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
867 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
868 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
869 1J1X 2 H Ig VH,anti-lysozyme 10090
870 5L8K 2 B New antigen receptor variable domain 168098
871 5M2J 2 D Anti-(ED-B) scFV 9606
872 3MXW 2 L 5E1 light chain 9606
873 3MXW 3 H 5E1 heavy chain 9606
874 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
875 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
876 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
877 2DQC 2 H Ig VH,anti-lysozyme 10090
878 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
879 1J1O 2 H Ig VH,anti-lysozyme 10090
880 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
881 3EO9 1 L Efalizumab Fab fragment, light chain 9606
882 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
883 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
884 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
885 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
886 4M62 2 H, I GEP2 FV heavy chain 9606
887 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
888 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
889 5IVO 1 A BC2-nanobody 30538
890 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
891 1J1P 2 H Ig VH,anti-lysozyme 10090
892 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
893 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
894 4NBZ 2 B, D A26.8 VHH 9844
895 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
896 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
897 5WUV 1 L light chain 9606
898 5WUV 2 H heavy chain 9606
899 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
900 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
901 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
902 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
903 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
904 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
905 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
906 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
907 5AYU 2 H Ig VH,anti-lysozyme 10090
908 4JM4 1 H PGT 135 Heavy Chain Fab 9606
909 4JM4 2 L PGT 135 Light Chain Fab 9606
910 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
911 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
912 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
913 3A6B 2 H IG VH, anti-lysozyme 10090
914 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
915 2DQJ 2 H Ig VH,anti-lysozyme 10090
916 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
917 5YE4 2 B, D 1A9D7 L chain 10090
918 5F21 2 B nanobody MU375 9844
919 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
920 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
921 6B0G 1 C 1245 Antibody, Light Chain 9606
922 6B0G 2 D 1245 Antibody, Heavy Chain 9606
923 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
924 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
925 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
926 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
927 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
928 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
929 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain